logo-loader

Sinovac Biotech

Receive alerts
Market:
NYSE
Market Cap:
-
Price
USD
Change
-
52 weeks high
-
52 weeks low
-

In brief

Sinovac Biotech (also known in China as Beijing Kexing Bioproducts) specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as Hepatitis A and Hepatitis B, influenza and “SARS”. Sinovac is one of the leading emerging biotechnology companies in China.